vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and ATRenew Inc. (RERE). Click either name above to swap in a different company.

Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $43.2M, roughly 1.8× ATRenew Inc.). ATRenew Inc. runs the higher net margin — 16.9% vs -9.6%, a 26.5% gap on every dollar of revenue.

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

ATRenew Inc. operates a leading pre-owned consumer electronics transaction and servicing ecosystem primarily in China. Its core services include end-to-end device recycling, professional quality inspection, certified refurbishment, and resale of smartphones, laptops, tablets and other digital products, serving both individual consumers and enterprise clients across domestic and select Southeast Asian markets.

BIOX vs RERE — Head-to-Head

Bigger by revenue
BIOX
BIOX
1.8× larger
BIOX
$77.6M
$43.2M
RERE
Higher net margin
RERE
RERE
26.5% more per $
RERE
16.9%
-9.6%
BIOX

Income Statement — Q1 FY2026 vs Q1 FY2023

Metric
BIOX
BIOX
RERE
RERE
Revenue
$77.6M
$43.2M
Net Profit
$-7.4M
$7.3M
Gross Margin
46.8%
Operating Margin
9.3%
Net Margin
-9.6%
16.9%
Revenue YoY
-16.8%
Net Profit YoY
-20.2%
EPS (diluted)
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
RERE
RERE
Q3 25
$77.6M
Q1 25
$60.6M
Q4 24
$98.8M
Q3 24
$93.3M
Q1 24
$84.0M
Q4 23
$140.2M
Q3 23
$116.6M
Q1 23
$92.5M
$43.2M
Net Profit
BIOX
BIOX
RERE
RERE
Q3 25
$-7.4M
Q1 25
$-1.6M
Q4 24
$605.2K
Q3 24
$-6.2M
Q1 24
$9.8M
Q4 23
$1.2M
Q3 23
$-2.7M
Q1 23
$27.5M
$7.3M
Gross Margin
BIOX
BIOX
RERE
RERE
Q3 25
46.8%
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q1 24
50.8%
Q4 23
36.7%
Q3 23
38.6%
Q1 23
62.1%
Operating Margin
BIOX
BIOX
RERE
RERE
Q3 25
9.3%
Q1 25
1.5%
Q4 24
14.5%
Q3 24
2.5%
Q1 24
15.7%
Q4 23
12.0%
Q3 23
4.5%
Q1 23
32.3%
Net Margin
BIOX
BIOX
RERE
RERE
Q3 25
-9.6%
Q1 25
-2.6%
Q4 24
0.6%
Q3 24
-6.6%
Q1 24
11.6%
Q4 23
0.9%
Q3 23
-2.3%
Q1 23
29.7%
16.9%
EPS (diluted)
BIOX
BIOX
RERE
RERE
Q3 25
$-0.12
Q1 25
$-0.02
Q4 24
$0.00
Q3 24
$-0.10
Q1 24
$0.14
Q4 23
$0.00
Q3 23
$-0.07
Q1 23
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
RERE
RERE
Cash + ST InvestmentsLiquidity on hand
$15.5M
$228.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$557.1M
Total Assets
$734.9M
$722.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
RERE
RERE
Q3 25
$15.5M
Q1 25
$38.5M
Q4 24
$29.2M
Q3 24
$32.3M
Q1 24
$16.4M
Q4 23
$24.4M
Q3 23
$28.4M
Q1 23
$57.7M
$228.0M
Stockholders' Equity
BIOX
BIOX
RERE
RERE
Q3 25
$288.3M
Q1 25
$345.0M
Q4 24
$346.3M
Q3 24
$346.0M
Q1 24
$348.5M
Q4 23
$335.3M
Q3 23
$332.6M
Q1 23
$334.3M
$557.1M
Total Assets
BIOX
BIOX
RERE
RERE
Q3 25
$734.9M
Q1 25
$798.2M
Q4 24
$835.2M
Q3 24
$827.3M
Q1 24
$836.1M
Q4 23
$819.5M
Q3 23
$819.7M
Q1 23
$846.8M
$722.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
RERE
RERE
Operating Cash FlowLast quarter
$14.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
RERE
RERE
Q3 25
$14.4M
Q1 25
$23.3M
Q4 24
$-5.4M
Q3 24
$5.2M
Q1 24
$-17.4M
Q4 23
$21.1M
Q3 23
$14.7M
Q1 23
$2.2M
Cash Conversion
BIOX
BIOX
RERE
RERE
Q3 25
Q1 25
Q4 24
-8.85×
Q3 24
Q1 24
-1.78×
Q4 23
17.05×
Q3 23
Q1 23
0.08×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons